Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40WD8 | ISIN: CA25244H1055 | Ticker-Symbol: X8F
Tradegate
11.05.26 | 12:59
0,172 Euro
+4,24 % +0,007
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
DIAGNOSTEAR TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
DIAGNOSTEAR TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0000,00012.05.

Aktuelle News zur DIAGNOSTEAR TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiBreaking News: Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
DIAGNOSTEAR TECHNOLOGIES Aktie jetzt für 0€ handeln
DiDiagnosTear Technologies Inc.: DiagnosTear Secures Exclusive Global Rights to CLARIFY Eye Imaging Platform for Needle-Free Blood Diagnostics319Vancouver, British Columbia--(Newsfile Corp. - May 12, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a leader in rapid, eye-based diagnostic technologies...
► Artikel lesen
FrDiagnostear Technologies Inc: Diagnostear shareholders approve all matters at AGM1
DoDiagnosTear Technologies Inc.: DiagnosTear Technologies Inc. Announces Results of AGM243Vancouver, British Columbia--(Newsfile Corp. - May 7, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company") is pleased to announce results of its annual general...
► Artikel lesen
05.05.Diagnostear Technologies Inc: Diagnostear Technologies extends warrants17
21.04.DiagnosTear Technologies Inc.: DiagnosTear Technologies Inc. Announces Adoption of Semi-Annual Reporting510Vancouver, British Columbia--(Newsfile Corp. - April 21, 2026) - DiagnosTear Technologies Inc. ("DiagnosTear" or the "Company") announces that it has adopted a semi-annual financial reporting ("SAR")...
► Artikel lesen
26.02.DiagnosTear Technologies Inc.: DiagnosTear Announces Regulatory Approvals in France and Study Initiation with AlyaTec for TeaRx Red Eye394Vancouver, British Columbia--(Newsfile Corp. - February 26, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care...
► Artikel lesen
21.02.Diagnostear Technologies Inc: Diagnostear signs U.K. LOI with Hanson Medical9
20.02.DiagnosTear Technologies Inc.: DiagnosTear Advances UK Market Entry Through Commercial Collaboration with Hanson Medical896Vancouver, British Columbia--(Newsfile Corp. - February 20, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of rapid point-of-care diagnostics...
► Artikel lesen
22.01.Diagnostear Technologies Inc: Diagnostear Technologies moves to expand in India2
22.01.DiagnosTear Technologies Inc.: DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx in India379Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), an innovator in point-of-care ocular diagnostics...
► Artikel lesen
17.01.Diagnostear Technologies Inc: Diagnostear receives interim clinical results for TeaRx4
17.01.DiagnosTear Technologies Inc.: DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx Red Eye767Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care...
► Artikel lesen
18.12.25DiagnosTear Technologies Inc.: DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count757Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a leader in rapid eye based diagnostic technologies...
► Artikel lesen
15.12.25DiagnosTear: A diagnostic technology stock at the forefront of ocular disease5
10.12.25Diagnostear Technologies Inc: Diagnostear does not say why stock is up6
09.12.25DiagnosTear Technologies Inc. - Confirmation of No Material Change516Vancouver, British Columbia--(Newsfile Corp. - December 9, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular...
► Artikel lesen
02.12.25DiagnosTear Technologies Inc.: DiagnosTear Announces Clinical Study with AlyaTec to Advance Analytical Validation and FDA Submission Pathway of TeaRx Red Eye Diagnostic Test496Vancouver, British Columbia--(Newsfile Corp. - December 2, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular...
► Artikel lesen
27.11.25Diagnostear Technologies Inc: Diagnostear, LV Prasad enter partnership for TeaRx3
26.11.25DiagnosTear Technologies Inc.: DiagnosTear Technologies Announces Initiation of a Collaboration with LV Prasad Eye Institute for Advancing the Clinical Validation of TeaRx Red Eye Diagnostic Test488Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) ("DiagnosTear" or the "Company"), a leader in developing cutting-edge point-of-care eye...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1